Skip to Main Content
TABLE 2

Odds Ratios of Metabolic Monitoring by Provider Type, Florida and Texas Combined (2017)

Provider VariablesOverall (Texas and Florida Combined)Adjusted Model by StateState and Provider Interaction, P
UnadjustedaAdjustedbFloridaTexas
Odds Ratio (95% CI)POdds Ratio (95% CI)POdds Ratio (95% CI)POdds Ratio (95% CI)P
During the year, ≥1 visit         .0319 
 PCP Reference — Reference — Reference — Reference — — 
 MHP 0.80 (0.73–0.89) <.001 0.77 (0.69–0.86) <.001 0.64 (0.54–0.76) <.001 0.87 (0.75–1.00) .055 — 
 PCP and MHP 1.72 (1.62–1.82) <.001 1.42 (1.32–1.52) <.001 1.31 (1.16–1.47) <.001 1.47 (1.35–1.60) <.001 — 
Majority prescribing provider         .2709 
 PCP Reference — Reference — Reference — Reference — — 
 MHP 1.45 (1.36–1.54) <.001 1.25 (1.17–1.33) <.001 1.19 (1.05–1.34) .006 1.27 (1.18–1.38) <.001 — 
 Other 1.21 (1.11–1.33) <.001 1.20 (1.08–1.32) <.001 1.25 (1.07–1.45) .005 1.14 (1.00–1.30) .048 — 
Provider VariablesOverall (Texas and Florida Combined)Adjusted Model by StateState and Provider Interaction, P
UnadjustedaAdjustedbFloridaTexas
Odds Ratio (95% CI)POdds Ratio (95% CI)POdds Ratio (95% CI)POdds Ratio (95% CI)P
During the year, ≥1 visit         .0319 
 PCP Reference — Reference — Reference — Reference — — 
 MHP 0.80 (0.73–0.89) <.001 0.77 (0.69–0.86) <.001 0.64 (0.54–0.76) <.001 0.87 (0.75–1.00) .055 — 
 PCP and MHP 1.72 (1.62–1.82) <.001 1.42 (1.32–1.52) <.001 1.31 (1.16–1.47) <.001 1.47 (1.35–1.60) <.001 — 
Majority prescribing provider         .2709 
 PCP Reference — Reference — Reference — Reference — — 
 MHP 1.45 (1.36–1.54) <.001 1.25 (1.17–1.33) <.001 1.19 (1.05–1.34) .006 1.27 (1.18–1.38) <.001 — 
 Other 1.21 (1.11–1.33) <.001 1.20 (1.08–1.32) <.001 1.25 (1.07–1.45) .005 1.14 (1.00–1.30) .048 — 

CI, confidence interval; —, not applicable.

a

Unadjusted odds ratios are derived from the GEE model (accounting for most seen NPIs during the year) of only the individual provider variable and including only state as a covariate.

b

Adjusted odds ratios are derived from GEE models described above with both provider variables but also include as covariates the following patient characteristics: indicator of whether the behavioral health diagnosis is an accepted condition for use of antipsychotic, any cardiometabolic diagnosis (described in a footnote for Table 1), enrolled in foster care, age, sex, race and/or ethnicity, RUCC category, and SVI quartile.

Close Modal

or Create an Account

Close Modal
Close Modal